CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-24 | Nussbaum Ran Director | Purchase | +24,000 | $9.00 | $216K | 24,000 |
| 2019-06-24 | Kariv Tomer Director | Purchase | +42,261 | $9.00 | $380K | 510,846 |
| 2019-06-24 | Kariv Tomer Director | Purchase | +86,806 | $9.00 | $781K | 1,049,310 |
| 2019-06-24 | Kariv Tomer Director | Purchase | +46,933 | $9.00 | $422K | 567,329 |
| 2019-06-24 | Kariv Tomer Director | Purchase | +24,000 | $9.00 | $216K | 24,000 |
| 2019-06-24 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +42,261 | $9.00 | $380K | 510,846 |
| 2019-06-24 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +86,806 | $9.00 | $781K | 1,049,310 |
| 2019-06-24 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +46,933 | $9.00 | $422K | 567,329 |
| 2019-06-24 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +24,000 | $9.00 | $216K | 24,000 |
| 2019-05-29 | Nussbaum Ran Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Kleijwegt Martijn Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Noiman Silvia Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Nussbaum Ran Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Avnur Zafrira Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Kariv Tomer Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Rubin Steven D Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Seehra Jasbir Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-05-29 | Veinrib Gadi Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 12 of 20 · 388 trades